122 related articles for article (PubMed ID: 8174206)
1. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study.
Stöger H; Bauernhofer T; Kasparek AK; Schmid M; Moser R; Ploner F; Derstvenscheg E; Kuss I; Wilders-Truschnig M; Steindorfer P
Cancer Chemother Pharmacol; 1994; 34(1):75-8. PubMed ID: 8174206
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer.
Stöger H; Schmid M; Bauernhofer T; Moser R; Ploner F; Derstvenscheg E; Kasparek AK; Kuss I; Wilders-Truschnig M; Lackner C
Oncology; 1994; 51(6):518-22. PubMed ID: 7970497
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
Stöger H; Bauernhofer T; Schmid M; Ploner F; Moser R; Derstvenscheg E; Steindorfer P; Wilders-Truschnig M; Kuss I; Samonigg H
Cancer Chemother Pharmacol; 1994; 35(2):174-8. PubMed ID: 7987997
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide plus epidoxorubicin and 5-fluorouracil with folinic acid as a novel treatment in metastatic breast cancer: preliminary results of a phase II study.
Palmeri S; Gebbia V; Russo A; Gebbia N; Meli M; Rausa L
J Chemother; 1991 Jun; 3(3):176-9. PubMed ID: 1919655
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
7. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
Nolè F; de Braud F; Aapro M; Minchella I; De Pas TM; Zampino MG; Monti S; Andreoni G; Goldhirsch A
Ann Oncol; 1997 Sep; 8(9):865-70. PubMed ID: 9358936
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
[TBL] [Abstract][Full Text] [Related]
9. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
[TBL] [Abstract][Full Text] [Related]
11. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
[TBL] [Abstract][Full Text] [Related]
12. Levo folinic acid and 5-fluorouracil plus high dose epidoxorubicin as first line treatment for metastatic breast carcinoma.
Gebbia V; Testa A; Valenza R; Cipolla C; Amato C; Latteri M; Gebbia N; Florena M
Anticancer Res; 1993; 13(1):141-4. PubMed ID: 8386492
[TBL] [Abstract][Full Text] [Related]
13. Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.
Francini G; Petrioli R; Aquino A; Gonnelli S
Cancer Chemother Pharmacol; 1993; 32(5):359-64. PubMed ID: 7687933
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.
Marini G; Marpicati P; Zaniboni A; Cervi GC; Gorni F; Simoncini E
Chemioterapia; 1985 Apr; 4(2):135-8. PubMed ID: 3874000
[TBL] [Abstract][Full Text] [Related]
16. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
17. A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma.
Callari A; Gebbia V; Testa A; Cusimano MP; Cipolla C; Amato C; Cannata G; Latteri MA; Garascia C; Gebbia N
Acta Oncol; 1994; 33(8):925-9. PubMed ID: 7529516
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer.
Klaassen U; Harstrick A; Wilke H; Seeber S
Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037
[TBL] [Abstract][Full Text] [Related]
20. Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM).
Colucci G; Maiello E; Gebbia V; Cifarelli RA; Biglietto M; Pedicini A; Durini E; Giuliani F; Gebbia N
Oncology; 1996; 53(4):269-74. PubMed ID: 8692529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]